Table 1.
Correlation between ELOVL1 expression and clinicopathological characteristics of HCC patients in TCGA.
Clinicopathological Parameter | Total | Expression of ELOVL1 | P-Value | |
---|---|---|---|---|
Low | High | |||
Gender | 0.475 | |||
Male | 108 | 63 | 45 | |
Female | 236 | 148 | 88 | |
Age | 0.825 | |||
<60 | 162 | 98 | 64 | |
≧60 | 182 | 113 | 69 | |
Tumor grade | 0.001 | |||
G1-G2 | 213 | 146 | 67 | |
G3-G4 | 131 | 65 | 66 | |
Tumor stage | 0.078 | |||
S1–S2 | 254 | 163 | 91 | |
S3–S4 | 90 | 48 | 42 | |
Tumor T stage | 0.037 | |||
T1–T2 | 256 | 165 | 91 | |
T3–T4 | 88 | 46 | 42 | |
Lymph node metastasis | 0.154 | |||
Yes | 91 | 60 | 31 | |
No | 253 | 151 | 102 | |
Metastasis | 0.65 | |||
Yes | 82 | 57 | 25 | |
No | 262 | 154 | 108 |